Report Detail
Global (United States, European Union and China) Human Insulin Market Research Report 2019-2025
- RnM3635653 |
- 30 July, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Human insulin is the name which describes synthetic insulin which is laboratory grown to mimic the insulin in humans.
In 2018, North America is estimated to dominate the global human insulin market. The Asia-Pacific market is poised to grow the fastest, during the forecast period, owing to growing diabetes prevalence in APAC (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, evolving regulatory framework for marketing approvals & medical reimbursements, continued expansion of advanced medical facilities in emerging countries (such as China & India), and rising public awareness related to benefits offered by human insulin in diabetes treatment.
In 2019, the market size of Human Insulin is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Insulin.
This report studies the global market size of Human Insulin, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Human Insulin sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
B. Braun
Becton, Dickinson
Biocon
Biodel
ELI Lilly
Julphar
NOVO Nordisk
Sanofi
Wockhardt
Ypsomed
Market Segment by Product Type
Insulin Analogs and Biosimilars
Human Insulin Biologics
Market Segment by Application
Short acting
Intermediate acting
Long acting
Pre-mix Insulin
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Human Insulin status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Human Insulin manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Human Insulin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Human Insulin Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Insulin Analogs and Biosimilars
- 1.3.3 Human Insulin Biologics
- 1.4 Market Segment by Application
- 1.4.1 Global Human Insulin Market Share by Application (2019-2025)
- 1.4.2 Short acting
- 1.4.3 Intermediate acting
- 1.4.4 Long acting
- 1.4.5 Pre-mix Insulin
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Human Insulin Market Size
- 2.1.1 Global Human Insulin Revenue 2014-2025
- 2.1.2 Global Human Insulin Sales 2014-2025
- 2.2 Human Insulin Growth Rate by Regions
- 2.2.1 Global Human Insulin Sales by Regions 2014-2019
- 2.2.2 Global Human Insulin Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Human Insulin Sales by Manufacturers
- 3.1.1 Human Insulin Sales by Manufacturers 2014-2019
- 3.1.2 Human Insulin Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Human Insulin Revenue by Manufacturers (2014-2019)
- 3.2.2 Human Insulin Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Human Insulin Market Concentration Ratio (CR5 and HHI)
- 3.3 Human Insulin Price by Manufacturers
- 3.4 Key Manufacturers Human Insulin Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Human Insulin Market
- 3.6 Key Manufacturers Human Insulin Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Insulin Analogs and Biosimilars Sales and Revenue (2014-2019)
- 4.1.2 Human Insulin Biologics Sales and Revenue (2014-2019)
- 4.2 Global Human Insulin Sales Market Share by Type
- 4.3 Global Human Insulin Revenue Market Share by Type
- 4.4 Human Insulin Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Human Insulin Sales by Application
6 United States
- 6.1 United States Human Insulin Breakdown Data by Company
- 6.2 United States Human Insulin Breakdown Data by Type
- 6.3 United States Human Insulin Breakdown Data by Application
7 European Union
- 7.1 European Union Human Insulin Breakdown Data by Company
- 7.2 European Union Human Insulin Breakdown Data by Type
- 7.3 European Union Human Insulin Breakdown Data by Application
8 China
- 8.1 China Human Insulin Breakdown Data by Company
- 8.2 China Human Insulin Breakdown Data by Type
- 8.3 China Human Insulin Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Human Insulin Breakdown Data by Company
- 9.2 Rest of World Human Insulin Breakdown Data by Type
- 9.3 Rest of World Human Insulin Breakdown Data by Application
- 9.4 Rest of World Human Insulin Breakdown Data by Countries
- 9.4.1 Rest of World Human Insulin Sales by Countries
- 9.4.2 Rest of World Human Insulin Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 B. Braun
- 10.1.1 B. Braun Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Human Insulin
- 10.1.4 Human Insulin Product Introduction
- 10.1.5 B. Braun Recent Development
- 10.2 Becton, Dickinson
- 10.2.1 Becton, Dickinson Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Human Insulin
- 10.2.4 Human Insulin Product Introduction
- 10.2.5 Becton, Dickinson Recent Development
- 10.3 Biocon
- 10.3.1 Biocon Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Human Insulin
- 10.3.4 Human Insulin Product Introduction
- 10.3.5 Biocon Recent Development
- 10.4 Biodel
- 10.4.1 Biodel Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Human Insulin
- 10.4.4 Human Insulin Product Introduction
- 10.4.5 Biodel Recent Development
- 10.5 ELI Lilly
- 10.5.1 ELI Lilly Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Human Insulin
- 10.5.4 Human Insulin Product Introduction
- 10.5.5 ELI Lilly Recent Development
- 10.6 Julphar
- 10.6.1 Julphar Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Human Insulin
- 10.6.4 Human Insulin Product Introduction
- 10.6.5 Julphar Recent Development
- 10.7 NOVO Nordisk
- 10.7.1 NOVO Nordisk Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Human Insulin
- 10.7.4 Human Insulin Product Introduction
- 10.7.5 NOVO Nordisk Recent Development
- 10.8 Sanofi
- 10.8.1 Sanofi Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Human Insulin
- 10.8.4 Human Insulin Product Introduction
- 10.8.5 Sanofi Recent Development
- 10.9 Wockhardt
- 10.9.1 Wockhardt Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Human Insulin
- 10.9.4 Human Insulin Product Introduction
- 10.9.5 Wockhardt Recent Development
- 10.10 Ypsomed
- 10.10.1 Ypsomed Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Human Insulin
- 10.10.4 Human Insulin Product Introduction
- 10.10.5 Ypsomed Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Human Insulin Sales Channels
- 11.2.2 Human Insulin Distributors
- 11.3 Human Insulin Customers
12 Market Forecast
- 12.1 Global Human Insulin Sales and Revenue Forecast 2019-2025
- 12.2 Global Human Insulin Sales Forecast by Type
- 12.3 Global Human Insulin Sales Forecast by Application
- 12.4 Human Insulin Forecast by Regions
- 12.4.1 Global Human Insulin Sales Forecast by Regions 2019-2025
- 12.4.2 Global Human Insulin Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Human Insulin. Industry analysis & Market Report on Human Insulin is a syndicated market report, published as Global (United States, European Union and China) Human Insulin Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Human Insulin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
